| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Chambers Michael Andrew is a Director at Sarepta Therapeutics, Inc.. Recent SEC Form 4 filings include 14 buys and 0 sells.
Estimated insider holdings value: $213K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 37,038 | $133.80 | $4,955,728.14 | +4.7% | -18.2% | -83.7% | |
| Aug 14, 2023 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 9,979 | $109.47 | $1,092,429.41 | +2.1% | -29.1% | +18.7% | |
| Aug 11, 2023 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 23,686 | $108.05 | $2,559,272.30 | +11.1% | -26.7% | +16.0% | |
| Aug 10, 2023 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 34,867 | $106.15 | $3,701,067.12 | +6.4% | -23.9% | +18.2% | |
| Sep 14, 2022 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 57,100 | $104.43 | $5,963,124.30 | +25.4% | +14.2% | +11.3% | |
| Aug 19, 2022 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 46,170 | $108.28 | $4,999,230.00 | +92.5% | +1.9% | +3.7% |